Profound Medical Corp (id:13577 PRN)
10.61 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 5:51:03 AM)
Exchange closed, opens in 2 days 3 hours
About Profound Medical Corp
Market Capitalization 278.68M
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
| Headquarters (address) |
2400 Skymark Avenue Mississauga L4W 5K5 ON Canada |
| Phone | 647 476 1350 |
| Website | https://www.profoundmedical.com |
| Employees | 131 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | PRN |
| Exchange | Toronto Stock Exchange |
| Currency | CAD |
| 52 week range | 9.55 - 15.75 |
| Market Capitalization | 278.68M |
| P/E trailing | -7.81 |
| P/E forward | -9.83 |
| Price/Sale | 31.02 |
| Price/Book | 8.96 |
| Beta | 0.830 |
| EPS | -1.87 |
| EPS Canada (ID:82, base:723) | 1.83 |